Thread Tools Display Modes
Prev Previous Post   Next Post Next
Old 04-11-2013, 01:24 PM #14
AlwaysLateMommy AlwaysLateMommy is offline
New Member
 
Join Date: Apr 2013
Posts: 2
10 yr Member
AlwaysLateMommy AlwaysLateMommy is offline
New Member
 
Join Date: Apr 2013
Posts: 2
10 yr Member
Grin

I too am in this study! Unfortunately, I'm positive I got the Rebif and not the study drug. My sister is in a different study with a similar drug (alumtuzimab), and she did get the study drug and is doing really well! Be happy your Rebif is placebo - because I am up to the 44 dose now and last night was NOT fun. I'm beginning to wonder if I can do the Rebif - walking around everyday feeling like you have the flu and a migraine is NOT quality of life...

On the plus side, even though I am on the Rebif, at the end of the study I have the option to go on the study drug. So only two more years of injections to go...
AlwaysLateMommy is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
SallyC (04-11-2013)
 


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


Similar Threads
Thread Thread Starter Forum Replies Last Post
Ocrelizumab drug trial? jprinz99 Arthritis 3 04-05-2010 08:36 AM
Some of you may remember suzyqz_2007 Pets & Wildlife 4 12-22-2008 08:53 PM
Ocrelizumab? jprinz99 Autoimmune Diseases 3 10-21-2008 10:16 PM


All times are GMT -5. The time now is 03:54 PM.


Powered by vBulletin • Copyright ©2000 - 2025, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise (Lite) - vBulletin Mods & Addons Copyright © 2025 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.